Premium
Appraisal of guidelines for androgenetic alopecia using the A ppraisal of G uidelines for R esearch and E valuation II instrument
Author(s) -
Huang Mengya,
Zhou Xun
Publication year - 2015
Publication title -
journal of evaluation in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.737
H-Index - 73
eISSN - 1365-2753
pISSN - 1356-1294
DOI - 10.1111/jep.12474
Subject(s) - valuation (finance) , advertising , business , finance
Rationale, aims and objectives The purpose of this study is to systematically evaluate the quality of methodological guidelines for androgenetic alopecia ( AGA ) using the A ppraisal of G uidelines for R esearch and E valuation ( AGREE ) II instrument by searching and analysing the available worldwide guidelines. This could provide a reference for selecting clinical guidelines and for developing new guidelines in the future. Methods We searched P ub M ed and other electronic databases for any AGA guidelines published until 2014. The AGREE II instrument was used by two researchers to create a systematic appraisal in six domains to determine the guidelines fulfilling the inclusion and exclusion criteria. Results Five guidelines associated with the therapy of AGA were identified. The mean scores for the six AGREE II domains were as follows: 89.45% for ‘scope and purpose’, 53.88% for ‘stakeholder involvement’, 53.96% for ‘rigour of development’, 87.22% for ‘clarity of presentation’, 42.92% for ‘applicability’ and 59.16% for ‘editorial independence’. The E uropean guideline ranked the highest, whereas the A merican guideline of 1996 ranked the lowest. The A sian, E uropean and J apanese guidelines were strongly recommended, and the two from A merica were recommended with modifications. Conclusions Guidelines should provide accurate and evidence‐based recommendations. The AGREE II instrument is a useful tool to improve the quality of guidelines, and high‐quality guidelines for clinical practice can be provided by using it.